ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Attenuated Japanese Encephalitis Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-34A14210
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live Attenuated Japanese Encephalitis Vaccine Market Research Report 2023
BUY CHAPTERS

Global Live Attenuated Japanese Encephalitis Vaccine Market Research Report 2025

Code: QYRE-Auto-34A14210
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Valneva
Bharat Biotech
Beijing Temple of Heaven Biological Products
Cheng Da Biology
Biocelect Pty Ltd
Glovax Co., Ltd.

Live Attenuated Japanese Encephalitis Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Live Attenuated Japanese Encephalitis Vaccine Market

Live Attenuated Japanese Encephalitis Vaccine Market

The global market for Live Attenuated Japanese Encephalitis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Epidemic Japanese encephalitis (hereinafter referred to as "JE") is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live Attenuated Japanese Encephalitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Japanese Encephalitis Vaccine.
The Live Attenuated Japanese Encephalitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Attenuated Japanese Encephalitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Japanese Encephalitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live Attenuated Japanese Encephalitis Vaccine Market Report

Report Metric Details
Report Name Live Attenuated Japanese Encephalitis Vaccine Market
CAGR 5%
Segment by Type
  • 0.5ml
  • 1ml
  • 2.5ml
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech, Cheng Da Biology, Biocelect Pty Ltd, Glovax Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live Attenuated Japanese Encephalitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live Attenuated Japanese Encephalitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Live Attenuated Japanese Encephalitis Vaccine Market report?

Ans: The main players in the Live Attenuated Japanese Encephalitis Vaccine Market are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech, Cheng Da Biology, Biocelect Pty Ltd, Glovax Co., Ltd.

What are the Application segmentation covered in the Live Attenuated Japanese Encephalitis Vaccine Market report?

Ans: The Applications covered in the Live Attenuated Japanese Encephalitis Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Live Attenuated Japanese Encephalitis Vaccine Market report?

Ans: The Types covered in the Live Attenuated Japanese Encephalitis Vaccine Market report are 0.5ml, 1ml, 2.5ml

Recommended Reports

Japanese Encephalitis

Viral & Infectious Vaccines

New Vaccine Technologies

1 Live Attenuated Japanese Encephalitis Vaccine Market Overview
1.1 Product Definition
1.2 Live Attenuated Japanese Encephalitis Vaccine by Type
1.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5ml
1.2.3 1ml
1.2.4 2.5ml
1.3 Live Attenuated Japanese Encephalitis Vaccine by Application
1.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue 2020-2031
1.4.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales 2020-2031
1.4.3 Global Live Attenuated Japanese Encephalitis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live Attenuated Japanese Encephalitis Vaccine Market Competition by Manufacturers
2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live Attenuated Japanese Encephalitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Date of Enter into This Industry
2.8 Global Live Attenuated Japanese Encephalitis Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Attenuated Japanese Encephalitis Vaccine Players Market Share by Revenue
2.8.3 Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Attenuated Japanese Encephalitis Vaccine Market Scenario by Region
3.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region: 2020-2031
3.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region: 2020-2025
3.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region: 2026-2031
3.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region: 2020-2031
3.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region: 2020-2025
3.3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region: 2026-2031
3.4 North America Live Attenuated Japanese Encephalitis Vaccine Market Facts & Figures by Country
3.4.1 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2031)
3.4.3 North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Japanese Encephalitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2031)
3.5.3 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Attenuated Japanese Encephalitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2020-2031)
4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2020-2025)
4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2026-2031)
4.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2020-2031)
4.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2020-2025)
4.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2026-2031)
4.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Live Attenuated Japanese Encephalitis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2020-2031)
5.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2020-2025)
5.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2026-2031)
5.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2020-2031)
5.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2020-2025)
5.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2026-2031)
5.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Live Attenuated Japanese Encephalitis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Chengdu Institute of Biological Products
6.3.1 Chengdu Institute of Biological Products Company Information
6.3.2 Chengdu Institute of Biological Products Description and Business Overview
6.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Company Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Lanzhou Institute of Biological Products
6.5.1 Lanzhou Institute of Biological Products Company Information
6.5.2 Lanzhou Institute of Biological Products Description and Business Overview
6.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.6 Beijing Temple of Heaven Biological Products
6.6.1 Beijing Temple of Heaven Biological Products Company Information
6.6.2 Beijing Temple of Heaven Biological Products Description and Business Overview
6.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.6.5 Beijing Temple of Heaven Biological Products Recent Developments/Updates
6.7 Valneva
6.7.1 Valneva Company Information
6.7.2 Valneva Description and Business Overview
6.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.7.5 Valneva Recent Developments/Updates
6.8 Bharat Biotech
6.8.1 Bharat Biotech Company Information
6.8.2 Bharat Biotech Description and Business Overview
6.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.8.5 Bharat Biotech Recent Developments/Updates
6.9 Cheng Da Biology
6.9.1 Cheng Da Biology Company Information
6.9.2 Cheng Da Biology Description and Business Overview
6.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.9.5 Cheng Da Biology Recent Developments/Updates
6.10 Biocelect Pty Ltd
6.10.1 Biocelect Pty Ltd Company Information
6.10.2 Biocelect Pty Ltd Description and Business Overview
6.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.10.5 Biocelect Pty Ltd Recent Developments/Updates
6.11 Glovax Co., Ltd.
6.11.1 Glovax Co., Ltd. Company Information
6.11.2 Glovax Co., Ltd. Description and Business Overview
6.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
6.11.5 Glovax Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Japanese Encephalitis Vaccine Industry Chain Analysis
7.2 Live Attenuated Japanese Encephalitis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Japanese Encephalitis Vaccine Production Mode & Process Analysis
7.4 Live Attenuated Japanese Encephalitis Vaccine Sales and Marketing
7.4.1 Live Attenuated Japanese Encephalitis Vaccine Sales Channels
7.4.2 Live Attenuated Japanese Encephalitis Vaccine Distributors
7.5 Live Attenuated Japanese Encephalitis Vaccine Customer Analysis
8 Live Attenuated Japanese Encephalitis Vaccine Market Dynamics
8.1 Live Attenuated Japanese Encephalitis Vaccine Industry Trends
8.2 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
8.3 Live Attenuated Japanese Encephalitis Vaccine Market Challenges
8.4 Live Attenuated Japanese Encephalitis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Valneva
Bharat Biotech
Beijing Temple of Heaven Biological Products
Cheng Da Biology
Biocelect Pty Ltd
Glovax Co., Ltd.
List of Tables
 Table 1. Global Live Attenuated Japanese Encephalitis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Live Attenuated Japanese Encephalitis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Live Attenuated Japanese Encephalitis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Live Attenuated Japanese Encephalitis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Live Attenuated Japanese Encephalitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live Attenuated Japanese Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Japanese Encephalitis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Live Attenuated Japanese Encephalitis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Live Attenuated Japanese Encephalitis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Live Attenuated Japanese Encephalitis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Live Attenuated Japanese Encephalitis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Live Attenuated Japanese Encephalitis Vaccine Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Chengdu Institute of Biological Products Company Information
 Table 81. Chengdu Institute of Biological Products Description and Business Overview
 Table 82. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product
 Table 84. Chengdu Institute of Biological Products Recent Developments/Updates
 Table 85. Wuhan Institute of Biological Products Company Information
 Table 86. Wuhan Institute of Biological Products Description and Business Overview
 Table 87. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product
 Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
 Table 90. Lanzhou Institute of Biological Products Company Information
 Table 91. Lanzhou Institute of Biological Products Description and Business Overview
 Table 92. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product
 Table 94. Lanzhou Institute of Biological Products Recent Developments/Updates
 Table 95. Beijing Temple of Heaven Biological Products Company Information
 Table 96. Beijing Temple of Heaven Biological Products Description and Business Overview
 Table 97. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product
 Table 99. Beijing Temple of Heaven Biological Products Recent Developments/Updates
 Table 100. Valneva Company Information
 Table 101. Valneva Description and Business Overview
 Table 102. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Valneva Live Attenuated Japanese Encephalitis Vaccine Product
 Table 104. Valneva Recent Developments/Updates
 Table 105. Bharat Biotech Company Information
 Table 106. Bharat Biotech Description and Business Overview
 Table 107. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product
 Table 109. Bharat Biotech Recent Developments/Updates
 Table 110. Cheng Da Biology Company Information
 Table 111. Cheng Da Biology Description and Business Overview
 Table 112. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product
 Table 114. Cheng Da Biology Recent Developments/Updates
 Table 115. Biocelect Pty Ltd Company Information
 Table 116. Biocelect Pty Ltd Description and Business Overview
 Table 117. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product
 Table 119. Biocelect Pty Ltd Recent Developments/Updates
 Table 120. Glovax Co., Ltd. Company Information
 Table 121. Glovax Co., Ltd. Description and Business Overview
 Table 122. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product
 Table 124. Glovax Co., Ltd. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Live Attenuated Japanese Encephalitis Vaccine Distributors List
 Table 128. Live Attenuated Japanese Encephalitis Vaccine Customers List
 Table 129. Live Attenuated Japanese Encephalitis Vaccine Market Trends
 Table 130. Live Attenuated Japanese Encephalitis Vaccine Market Drivers
 Table 131. Live Attenuated Japanese Encephalitis Vaccine Market Challenges
 Table 132. Live Attenuated Japanese Encephalitis Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live Attenuated Japanese Encephalitis Vaccine
 Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. 0.5ml Product Picture
 Figure 5. 1ml Product Picture
 Figure 6. 2.5ml Product Picture
 Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Live Attenuated Japanese Encephalitis Vaccine Report Years Considered
 Figure 16. Live Attenuated Japanese Encephalitis Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Live Attenuated Japanese Encephalitis Vaccine Players: Market Share by Revenue in Live Attenuated Japanese Encephalitis Vaccine in 2024
 Figure 19. Live Attenuated Japanese Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Live Attenuated Japanese Encephalitis Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Live Attenuated Japanese Encephalitis Vaccine by Type (2020-2031)
 Figure 53. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Live Attenuated Japanese Encephalitis Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Live Attenuated Japanese Encephalitis Vaccine by Application (2020-2031)
 Figure 56. Global Live Attenuated Japanese Encephalitis Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Live Attenuated Japanese Encephalitis Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025
Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
JE Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Japanese Encephalitis Vaccines Market Research Report 2024
Global Tick borne Encephalitis Vaccine Market Research Report 2024
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Live Vaccines Market Research Report 2024
Encephalitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Encephalitis Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Deletion Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Encephalomyelitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine for Human Rabies Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions